Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;34(1):95-103.
doi: 10.1038/nbt.3374. Epub 2015 Oct 26.

Comprehensive Characterization of the Published Kinase Inhibitor Set

Affiliations

Comprehensive Characterization of the Published Kinase Inhibitor Set

Jonathan M Elkins et al. Nat Biotechnol. .

Abstract

Despite the success of protein kinase inhibitors as approved therapeutics, drug discovery has focused on a small subset of kinase targets. Here we provide a thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 367 small-molecule ATP-competitive kinase inhibitors that was recently made freely available with the aim of expanding research in this field and as an experiment in open-source target validation. We screen the set in activity assays with 224 recombinant kinases and 24 G protein-coupled receptors and in cellular assays of cancer cell proliferation and angiogenesis. We identify chemical starting points for designing new chemical probes of orphan kinases and illustrate the utility of these leads by developing a selective inhibitor for the previously untargeted kinases LOK and SLK. Our cellular screens reveal compounds that modulate cancer cell growth and angiogenesis in vitro. These reagents and associated data illustrate an efficient way forward to increasing understanding of the historically untargeted kinome.

Similar articles

See all similar articles

Cited by 78 articles

See all "Cited by" articles

References

    1. Nat Biotechnol. 2006 Jul;24(7):805-15 - PubMed
    1. Mol Pharmacol. 2009 Oct;76(4):710-22 - PubMed
    1. Mol Inform. 2013 Oct;32(9-10):827-42 - PubMed
    1. Trends Pharmacol Sci. 2015 Jul;36(7):422-39 - PubMed
    1. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1773-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback